AGLE
Aeglea Bio Therapeutics Inc
Price:  
12.01 
USD
Volume:  
43,369.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AGLE Stock Forecast & Price Target

AGLE Stock Price Forecast

The average stock forecast for Aeglea Bio Therapeutics Inc (AGLE) in the next 12 months is 17.85 USD. This price target corresponds to an upside of 48.63%. The range of stock forecasts for AGLE is 12.12 - 24.15 USD. Based on the ratings of 0 analysts, the consensus recommendation for AGLE is HOLD.
Target Low Average Median High
Price (USD) 12.12 17.85 17.85 24.15
Upside 0.92% 48.63% 48.63% 101.08%

Recommendation Trends

The latest consensus rating for AGLE is "HOLD". This is the average recommendation of 0 analysts: strong sell, sell, hold, buy, strong buy. In the previous period, 0 analysts also majorly recommmended "HOLD" for AGLE.

AGLE Financial Stock Forecast

Revenue This Year
1.27M
-45.64%
from 2.33M
Revenue Next Year
13.33M
952.63%
from 1.27M
EPS This Year
-5.48
-73.52%
from -20.70
EPS Next Year
-2.38
-56.52%
from -5.48